Colesevelam Hydrochloride Patent Expiration
Colesevelam Hydrochloride is Used for lowering serum glucose levels in adults with type 2 diabetes mellitus and lowering cholesterol levels. It was first introduced by Cosette Pharmaceuticals Inc
Colesevelam Hydrochloride Patents
Given below is the list of patents protecting Colesevelam Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Welchol |
US7229613 (Pediatric) | Method for lowering serum glucose |
Oct 17, 2022
(Expired) | Cosette |
| Welchol | US7229613 | Method for lowering serum glucose |
Apr 17, 2022
(Expired) | Cosette |
| Welchol |
US5693675 (Pediatric) | Alkylated amine polymers |
Jun 02, 2015
(Expired) | Cosette |
| Welchol |
US5607669 (Pediatric) | Amine polymer sequestrant and method of cholesterol depletion |
Dec 10, 2014
(Expired) | Cosette |
| Welchol |
US5919832 (Pediatric) | Amine polymer sequestrant and method of cholesterol depletion |
Dec 10, 2014
(Expired) | Cosette |
| Welchol |
US6066678 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Dec 10, 2014
(Expired) | Cosette |
| Welchol |
US6433026 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Dec 10, 2014
(Expired) | Cosette |
| Welchol | US5693675 | Alkylated amine polymers |
Dec 02, 2014
(Expired) | Cosette |
| Welchol |
US5679717 (Pediatric) | Method for removing bile salts from a patient with alkylated amine polymers |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US5917007 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US5919832 (Pediatric) | Amine polymer sequestrant and method of cholesterol depletion |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US6066678 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US6433026 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US6784254 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol |
US7101960 (Pediatric) | Process for removing bile salts from a patient and alkylated compositions therefor |
Oct 29, 2014
(Expired) | Cosette |
| Welchol | US5607669 | Amine polymer sequestrant and method of cholesterol depletion |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
Jun 10, 2014
(Expired) | Cosette |
| Welchol | US5679717 | Method for removing bile salts from a patient with alkylated amine polymers |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US5917007 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US5919832 | Amine polymer sequestrant and method of cholesterol depletion |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US6066678 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US6433026 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US6784254 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
| Welchol | US7101960 | Process for removing bile salts from a patient and alkylated compositions therefor |
Apr 29, 2014
(Expired) | Cosette |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Colesevelam Hydrochloride's patents.
Latest Legal Activities on Colesevelam Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Colesevelam Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 29 Nov, 2018 | US7229613 |
| Expire Patent Critical | 08 Oct, 2018 | US7101960 |
| Maintenance Fee Reminder Mailed Critical | 16 Apr, 2018 | US7101960 |
| Post Issue Communication - Certificate of Correction | 24 Apr, 2008 | US7101960 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED Critical | 10 Mar, 2008 | US6784254 |
| Terminal Disclaimer Filed Critical | 04 Feb, 2008 | US6784254 |
| Patent Issue Date Used in PTA Calculation Critical | 12 Jun, 2007 | US7229613 |
| Recordation of Patent Grant Mailed Critical | 12 Jun, 2007 | US7229613 |
| Issue Notification Mailed Critical | 23 May, 2007 | US7229613 |
| Dispatch to FDC | 04 May, 2007 | US7229613 |
Colesevelam Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Colesevelam Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Colesevelam Hydrochloride. The first generic version for Colesevelam Hydrochloride was by Impax Laboratories Inc and was approved on May 16, 2018. And the latest generic version is by Impax Laboratories Llc and was approved on Jan 18, 2023.
Given below is the list of companies who have filed for Colesevelam Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | Oct 5, 2018 |
| 3.75GM/PACKET | for suspension | Prescription | ORAL | AB | May 6, 2019 |
2. BEIJING TIDE PHARM
Beijing Tide Pharmaceutical Co Ltd has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Beijing Tide Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | Oct 14, 2021 |
3. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | Sep 13, 2019 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
4. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Discontinued | ORAL | N/A | Dec 17, 2020 |
5. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | Oct 5, 2018 |
6. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | May 18, 2018 |
| 1.875GM/PACKET | for suspension | Prescription | ORAL | N/A | Jul 16, 2018 |
| 3.75GM/PACKET | for suspension | Prescription | ORAL | AB | Jul 16, 2018 |
7. IMPAX
Impax Laboratories Llc has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3.75GM/PACKET | for suspension | Discontinued | ORAL | N/A | Jan 18, 2023 |
Manufacturing Plant Locations New
Impax's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Impax as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
8. IMPAX LABS INC
Impax Laboratories Inc has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | May 16, 2018 |
9. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Discontinued | ORAL | N/A | Apr 20, 2020 |
10. INVENTIA
Inventia Healthcare Ltd has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Inventia.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | Dec 4, 2020 |
Manufacturing Plant Locations New
Inventia's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Inventia as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
11. UNITED RES LABS
United Research Laboratories Llc has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by United Res Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Discontinued | ORAL | N/A | Jan 21, 2022 |
12. WATSON LABS INC
Watson Laboratories Inc has filed for 3 different strengths of generic version for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3.75GM/PACKET | for suspension | Discontinued | ORAL | N/A | Sep 1, 2020 |
| 1.875GM/PACKET | for suspension | Discontinued | ORAL | N/A | Sep 1, 2020 |
| 625MG | tablet | Discontinued | ORAL | N/A | Sep 2, 2020 |
13. ZHEJIANG JINGXIN
Zhejiang Jingxin Pharmaceutical Co Ltd has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Zhejiang Jingxin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | Jul 15, 2020 |
14. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Colesevelam Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 625MG | tablet | Prescription | ORAL | AB | Oct 7, 2019 |